SCHEMBL1131983

SCHEMBL1131983

CCOC(=O)/C(C)=C/c1cc(-c2ccc(OCc3cc(C(=O)OC(C)(C)C)ccc3-c3ccc(Cl)cc3)cc2)n(C2CCCCC2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.36
GCGR P47871 2/20 0.34
CMKLR1 Q99788 2/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK1 P28482 1/20 0.34
FFAR1 O14842 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
FABP3 P05413 3/20 0.32
FABP4 P15090 3/20 0.32
BRD4 O60885 1/20 0.32
CACNB4 O00305 1/20 0.32
CACNA1A O00555 1/20 0.32
CACNA1G O43497 1/20 0.32
CACNG3 O60359 1/20 0.32
CACNA1F O60840 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNB3 P54284 1/20 0.32
CACNA2D1 P54289 1/20 0.32
CACNG7 P62955 1/20 0.32
CACNA1B Q00975 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1131984 1.00 FAAH (0.36) FAAHGCGRCMKLR1ALDH1A1MAPK1
SCHEMBL1131445 0.93 CMKLR1 (0.37) GCGRCMKLR1FFAR1FFAR4FABP3
SCHEMBL1131447 0.93 CMKLR1 (0.37) GCGRCMKLR1FFAR1FFAR4FABP3
SCHEMBL1132056 0.89 FAAH (0.37) FAAHGCGRCMKLR1FFAR1FFAR4
SCHEMBL1131367 0.88 FAAH (0.37) FAAHCMKLR1FFAR1FFAR4FABP3
SCHEMBL1131371 0.88 FAAH (0.37) FAAHCMKLR1FFAR1FFAR4FABP3
SCHEMBL1131986 0.82 CMKLR1 (0.36) FAAHGCGRCMKLR1FFAR1FFAR4
SCHEMBL1131767 0.81 GCGR (0.39) GCGRCMKLR1FFAR1FFAR4FABP3
SCHEMBL4049827 0.81 GCGR (0.39) GCGRCMKLR1FFAR1FFAR4FABP3
SCHEMBL1131843 0.80 CMKLR1 (0.40) CMKLR1FFAR1FFAR4FABP3FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP claimed
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP disclosed